FDA Approved: APRETUDE — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approves a supplemental application for APRETUDE (cabotegravir) filed by ViiV Healthcare Company. The action modifies the drug's labeling to reflect the new…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

SUPPL AP for APRETUDE (CABOTEGRAVIR)